On Tuesday, Shares of United Continental Holdings Inc (NYSE:UAL), subtract -1.25% and closed at $53.52 in the last trading session. The last trading range of the stock ranges between $53.18 and $54.94. The company’s Market capitalization is $17.71 Billion with the total Outstanding Shares of 322.41 million. During the 52-week trading session the minimum price at which share price traded, registered at $37.41 and reached to max level of $61.87. UAL’s September 2016 merged traffic (revenue passenger miles) raised 3.9 percent and merged capacity (available seat miles) raised 3.6 percent as compared to September 2015. UAL’s September 2016 merged load factor raised 0.3 points contrast to September 2015.
The company now anticipates third-quarter 2016 merged passenger unit revenue to decline 5.5 to 6.0 percent contrast to the third quarter of 2015. The year-over-year performance was mainly influenced by a strong U.S. dollar, lower surcharges, travel reductions from customers influenced by lower oil prices, competitive actions and passenger demand not growing at the same pace as industry capacity. The company’s merged passenger unit revenue result was near the top end of the initial guidance range mostly because of better than expected September close-in bookings driven by the timing of certain holidays.
Galena Biopharma Inc (NASDAQ:GALE), dropped -4.89% and closed at $0.288 in the last trading session. The last trading range of the stock ranges between $0.28 and $0.30. During the 52-week trading session the minimum price at which share price traded, registered at $0.28 and reached to max level of $2.49. Galena Biopharma, Inc. (GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs, presented interim safety data from the Company’s NeuVax™ (nelipepimut-S) Phase 2b combination study with trastuzumab at the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark. The clinical trial is a randomized, multicenter, investigator-sponsored, 300 patient Phase 2b study. It is presently enrolling HER2 1+ and 2+ node positive, and high-risk node negative patients to study NeuVax in combination with trastuzumab to prevent breast cancer recurrence.
Poster #1069P, entitled “Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression,” demonstrated that this novel combination of trastuzumab and NeuVax in HER2 low-expressing (LE) patients is well-tolerated and the cardiac effects of trastuzumab are not influenced by the addition of NeuVax.
On the otherhand Las Vegas Sands Corp. (NYSE:LVS), lost -0.19% and closed at $58.96 in the last trading session. The last trading range of the stock ranges between $58.77 and $60.00. The company’s Market capitalization is $47.41 billion with the total Outstanding Shares of 794.75 million. During the 52-week trading session the minimum price at which share price traded, registered at $34.88 and reached to max level of $60.00. Las Vegas Sands Corp. (LVS) accomplished part of its worldwide volunteer effort last Saturday, October 1 to build 100,000 hygiene kits this year for social enterprise Clean the World to assist improve the health and well-being of populations in need. Kits assembled last Saturday by volunteers at The Venetian Las Vegas will benefit a number of non-profit organizations in Las Vegas serving homeless populations in the area in addition to military families.
The volunteer event in Las Vegas at The Venetian is one of a series of hygiene kit builds at LVS’ properties in Macao, Singapore, Bethlehem and Las Vegas between July and December in 2016. The effort is part of LVS’s global corporate citizenship program, Sands Cares, and its ongoing partnership with Clean the World to support its mission of promoting good health and well-being around the globe through improved access to soap and hygiene education. This is the third successive year Las Vegas Sands has built hygiene kits for Clean the World, and the 2016 build events will bring the total number of hygiene kits created with Las Vegas Sands to nearly 500,000.